ASX:ADR Adherium (ADR) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Adherium Stock (ASX:ADR) 30 days 90 days 365 days Advanced Chart Get Adherium alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume38,277 shsAverage VolumeN/AMarket Capitalization$9.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAdherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around patient inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal, as well as Hailie remote patient management solution. The company was founded in 2001 and is based in Melbourne, Australia.Read More… Receive ADR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adherium and its competitors with MarketBeat's FREE daily newsletter. Email Address ADR Stock News HeadlinesAdherium Limited Announces Director’s Acquisition of Convertible NotesMay 22, 2025 | tipranks.comAdherium Limited Announces Convertible Notes IssuanceMay 18, 2025 | tipranks.comTrump’s Bitcoin Reserve is No Accident…For the first time in history, we have a president who understands crypto's potential to bypass the banking system entirely. And Wall Street's biggest players know it. I've created a blueprint revealing how everyday investors can turn this historic shift into potentially life-changing wealth. Like the 75,000 new millionaires created in the last bull run— only this time with institutional backing.May 28, 2025 | Crypto 101 Media (Ad)Adherium Secures $900,000 to Boost U.S. Expansion of Smartinhaler PlatformMay 18, 2025 | tipranks.comAdherium Limited Announces Director ChangeMay 8, 2025 | tipranks.comAdherium Limited Reports Over 100% Growth in US Commercial Patients and Expands Product LineApril 29, 2025 | tipranks.comAdherium Limited Announces Proposed Securities IssueMarch 18, 2025 | tipranks.comAdherium Secures $2.6 Million to Expand Hailie® Smartinhaler® in US MarketMarch 18, 2025 | tipranks.comSee More Headlines Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:ADR CIKN/A Webwww.adherium.com Phone64 9 307 2771FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$10.22 million Net Margins-1,215.74% Pretax MarginN/A Return on Equity-184.15% Return on Assets-57.95% Debt Debt-to-Equity Ratio1.44 Current Ratio2.90 Quick Ratio2.31 Sales & Book Value Annual Sales$2.35 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow10.00 Book ValueA$0.02 per share Price / BookN/AMiscellaneous Outstanding Shares333,440,000Free FloatN/AMarket Cap$9.10 million OptionableNot Optionable Beta2.40 The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (ASX:ADR) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredDollar Collapse Warning: Protect Your Wealth NOWGlobal central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adherium Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Adherium With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.